SCHEMBL6405730

SCHEMBL6405730

CC(=O)Oc1ccc2[nH]c(=O)n(NC(=O)c3cc4cc(C)ccc4[nH]3)c(=O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.47
PDGFRB P09619 2/20 0.45
PDGFRA P16234 2/20 0.45
FGFR1 P11362 1/20 0.45
FLT3 P36888 3/20 0.44
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
RXFP1 Q9HBX9 2/20 0.44
POLB P06746 1/20 0.43
PIN1 Q13526 1/20 0.42
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
PYGL P06737 1/20 0.40
PYGM P11217 1/20 0.40
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10085582 0.72 L3MBTL1 (0.46) TP53KDM4EALDH1A1HSD17B10HPGD
SCHEMBL6399564 0.71 HRH4 (0.52) RAB9ANPC1RXFP1PYGLPYGM
SCHEMBL6405492 0.68 ALDH1A1 (0.50) TP53FLT3POLBKDM4EALDH1A1
SCHEMBL9516560 0.67 PDGFRB (0.70) PDGFRBPDGFRAFGFR1PIN1KDM4E
SCHEMBL14845702 0.67 PIN1 (0.68) TP53PDGFRBPDGFRAFLT3RAB9A
SCHEMBL6398776 0.66 NHERF1 (0.55) RAB9ANPC1RXFP1PYGL
SCHEMBL14845690 0.66 PIN1 (0.62) TP53PDGFRBPDGFRAFLT3RAB9A
SCHEMBL13753366 0.66 RAB9A (0.62) TP53PDGFRBPDGFRAFLT3RAB9A
SCHEMBL15746114 0.65 PIN1 (0.66) TP53PDGFRBPDGFRAFLT3RAB9A
SCHEMBL27437787 0.65 KDM4E (0.61) PDGFRBPDGFRAFGFR1NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 TP53 1043/4885PDGFRB 2652/4885PDGFRA 1745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.